Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis

We compared progression-free survival (PFS) and overall survival (OS) among 292 metastatic renal cell carcinoma (mRCC) patients either undergoing nephrectomy (Nx, 61.6%) or not (non-Nx, 38.4%), stratified according to the MSKCC and Heng risk models, treated with either immunotherapy (IT, 45.2%) or t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Jeong, Kyung-Chae, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813006/
https://www.ncbi.nlm.nih.gov/pubmed/29445167
http://dx.doi.org/10.1038/s41598-018-20822-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813006/
https://www.ncbi.nlm.nih.gov/pubmed/29445167
http://dx.doi.org/10.1038/s41598-018-20822-2

Ejemplares similares